Antiretroviral preexposure prophylaxis ( PrEP ) , using daily oral combination tenofovir disoproxil fumarate plus emtricitabine , is an effective human immunodeficiency virus ( HIV ) prevention strategy for populations at high risk of HIV acquisition .